RxDoctor Payments Data

Nathan Vollbrecht

Psychiatric/Mental Health · Chandler, AZNPI 1932893591

Payments from drug & device makers

$3,383in general payments, 2019–2025

Across 174 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$480
  • Otsuka America Pharmaceutical, Inc.$418
  • Vanda Pharmaceuticals Inc.$380
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$341
  • Corium, LLC$325
  • Lundbeck LLC$197
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,381100%
  • Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,383 in reported general payments places this provider in the 90th percentile of 1,230 psychiatric/mental health providers in Arizona.

See all psychiatric/mental health providers in Arizona

Medicare billing

Part B allowed, 2024
$4,839
Medicare patients
39
Services billed
50

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine11$60,452
Invega SustennaPaliperidone Palmitate18$55,147
Abilify MaintenaAripiprazole21$53,977
Divalproex Sodium ErDivalproex Sodium59$4,150
Lurasidone Hcl45$3,996
Aripiprazole96$3,519
Quetiapine Fumarate134$3,210
Atomoxetine Hcl14$1,403
Duloxetine Hcl53$1,384
Fluphenazine Hcl15$1,372
Oxcarbazepine44$1,307
Ziprasidone Hcl13$1,258
Mirtazapine64$1,244
Clozapine26$1,219
Trazodone Hcl130$1,193

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$42$60,45211 claims
Johnson & JohnsonInvega Sustenna$43$55,14718 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$418$53,97721 claims
Almatica Pharma LLCSertraline Hcl$42$926142 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,230 psychiatric/mental health providers in Arizona.

Other psychiatric/mental health in Chandler

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →